Sponsors (2)
The bill centralizes and protects U.S. extremophile samples and data to accelerate domestic research and potential medical advances, but does so with nationality‑based access and export limits and open-ended federal spending that could hinder international collaboration and raise ethical and budgetary concerns.
U.S. researchers and scientists will get a coordinated national database of extremophile genomes and metabolites, making it faster and easier to discover new biological functions and accelerate biotechnology research.
Hospitals, health systems, and biomedical researchers may gain access to unique organisms and data that could support development of new diagnostics and treatments for diseases such as cancer, diabetes, and dementia.
Researchers, taxpayers, and the scientific community will benefit from a resilient, long‑term storage plan (a covered facility) that preserves biological samples through catastrophic incidents and protects national biological heritage for future research.
Scientists, students, and international collaborators will face limits on collaboration because database access restrictions and prohibitions on exporting physical samples to foreign persons can block reciprocal specimen sharing and slow international research partnerships.
Taxpayers may bear meaningful costs because building, operating, and sequencing activities for the covered facility are federally funded and authorized as 'such sums as necessary', creating uncertain and potentially substantial budgetary commitments.
Researchers and health institutions could face legal, ethical, and compliance challenges because nationality‑based restrictions on data and sample sharing raise questions about adherence to open‑science norms and existing data‑sharing standards.
Based on analysis of 2 sections of legislative text.
Creates a DOE-led program to collect, sequence, catalog, and securely store extremophile genomes/metabolites and plan a hardened long-term storage facility, with access restricted to U.S. persons where practicable.
Official title: Direct the Secretary of Energy to establish an extremophile whole genome sequencing initiative, and for other purposes.
Introduced July 15, 2026 by Marion Michael Rounds · Last progress July 15, 2026
Creates a federal program at the Department of Energy to collect, sequence, catalogue, and store whole genomes, peptides, metabolites, and associated metadata from animals, plants, fungi, and microbes found at selected extreme or at-risk locations. It requires use or establishment of a sequence database accessible to U.S. users, collaboration with outside partners, limits sharing with adversary nations/foreign persons to the maximum extent practicable, and a plan within one year to build a hardened long-term storage facility for the collected samples and material that can operate during catastrophic incidents. Sets short statutory deadlines: the Secretary of Energy must create the initiative within 90 days, DHS may contract for sample collection, the agency must select at least five sampling locations within 180 days (including at least one very deep underground mine), and the DOE must produce a plan for a long-term storage facility within one year. The program is intended to advance scientific discovery and potential health treatments consistent with the stated federal Genesis Mission goals in existing executive policy guidance.